(Q47281303)

English

Clinical predictors of early infarct-related artery patency following thrombolytic therapy: importance of body weight, smoking history, infarct-related artery and choice of thrombolytic regimen: the GUSTO-I experience. Global Utilization of Streptok

scientific article published in September 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9741505

Clinical predictors of early infarct-related artery patency following thrombolytic therapy: importance of body weight, smoking history, infarct-related artery and choice of thrombolytic regimen: the GUSTO-I experience. Global Utilization of Streptok (English)

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9741505

1 reference

based on heuristic

inferred from title

5

object named as

Califf RM

1 reference

Europe PubMed Central

13 January 2018

author name string

Lundergan CF

1

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9741505

Reiner JS

2

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9741505

McCarthy WF

3

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9741505

Coyne KS

4

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9741505

Ross AM

6

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9741505

language of work or name

0 references

publication date

1 September 1998

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9741505

Journal of the American College of Cardiology

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9741505

32

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9741505

3

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9741505

641-647

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9741505

Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900278-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Hemodynamic, mechanical, and metabolic determinants of thrombolytic efficacy: a theoretic framework for assessing the limitations of thrombolysis in patients with cardiogenic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900278-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900278-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900278-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900278-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Validation of probabilistic predictions

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900278-2

7 January 2021

based on heuristic

inferred from DOI database lookup

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900278-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved thrombolysis with a modified dose regimen of recombinant tissue-type plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900278-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Relation of reperfusion success with anistreplase or alteplase in acute myocardial infarction to body weight. The TEAM-3 investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900278-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Thrombolysis and Angioplasty in Myocardial Infarction (TAMI-1) trial: influence of infarct location on arterial patency, left ventricular function and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900278-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Multicenter patency trial of intravenous anistreplase compared with streptokinase in acute myocardial infarction. The TEAM-2 Study Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900278-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Invasive reperfusion study. II. Multicentre European randomized trial of anistreplase vs streptokinase in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900278-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Coronary reperfusion rates in acute myocardial infarction patients after thrombolytic treatment with anistreplase: correlation with the delay from onset of symptoms to treatment: a review of 424 case records of patients admitted to coronary reperfus

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900278-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors influencing probability of reperfusion with intracoronary ostial infusion of thrombolytic agent in patients with acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900278-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: mechanism of the "smoker's paradox" from the GUSTO-I trial, with angiographic insights. Global Utilization of Streptoki

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900278-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of cigarette smoking on coronary patency after thrombolytic therapy for myocardial infarction. TEAM-2 Investigators. Second Multicenter Thrombolytic Trials of Eminase in Acute Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900278-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute myocardial infarction treated with intracoronary streptokinase: A report of the society for cardiac angiography

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900278-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiographic patency study of anistreplase versus streptokinase in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900278-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Multicenter reperfusion trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: controlled comparison with intracoronary streptokinase

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900278-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900278-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Benefit of thrombolytic therapy is sustained throughout five years and is related to TIMI perfusion grade 3 but not grade 2 flow at discharge. The European Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900278-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Evolution of early TIMI 2 flow after thrombolysis for acute myocardial infarction. GUSTO-1 Angiographic Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900278-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved infarct-related arterial patency after high dose, weight-adjusted, rapid infusion of tissue-type plasminogen activator in myocardial infarction: results of a multicenter randomized trial of two dosage regimens.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900278-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Stroke after thrombolysis. Mortality and functional outcomes in the GUSTO-I trial. Global Use of Strategies to Open Occluded Coronary Arteries.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900278-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0735-1097(98)00278-2

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9741505

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9741505

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47281303&oldid=1408841257"